7.61 USD
-0.16 (-2.06%)
ChartMill assigns a Buy % Consensus number of 83% to XGN. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 15.74. This target is 106.8% above the current price.
XGN was analyzed by 12 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about XGN.
In the previous month the buy percentage consensus was at a similar level.
XGN was analyzed by 12 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-11-10 | BTIG | Maintains | Buy -> Buy |
| 2025-11-05 | B. Riley Securities | Reiterate | Buy -> Buy |
| 2025-10-27 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-10-22 | BTIG | Maintains | Buy -> Buy |
| 2025-10-14 | Keybanc | Maintains | Overweight -> Overweight |
| 2025-09-11 | B. Riley Securities | Initiate | Buy |
| 2025-07-30 | Keybanc | Upgrade | Sector Weight -> Overweight |
| 2025-07-30 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-07-23 | Craig-Hallum | Initiate | Buy |
| 2025-05-15 | Cantor Fitzgerald | Maintains | Overweight -> Overweight |
| 2025-05-13 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-01-13 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2025-01-03 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2024-05-14 | Cantor Fitzgerald | Maintains | Overweight -> Overweight |
| 2023-09-26 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2023-08-22 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2023-05-16 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2023-03-22 | BTIG | Maintains | Buy |
| 2022-11-17 | BTIG | Maintains | Buy |
| 2022-11-15 | Canaccord Genuity | Maintains | Buy |
| 2022-05-13 | Keybanc | Maintains | Overweight |
| 2021-11-11 | Keybanc | Maintains | Overweight |
| 2021-04-15 | Canaccord Genuity | Initiate | Buy |
| 2021-03-02 | Keybanc | Maintains | Overweight |
EXAGEN INC / XGN FAQ
Can you provide the average price target for EXAGEN INC stock?
12 analysts have analysed XGN and the average price target is 15.74 USD. This implies a price increase of 106.8% is expected in the next year compared to the current price of 7.61.
What is the consensus rating for EXAGEN INC (XGN) stock?
The consensus rating for EXAGEN INC (XGN) is 83.3333 / 100 . This indicates that analysts generally have a positive outlook on the stock.
Can you provide the analyst count for EXAGEN INC stock?
The number of analysts covering EXAGEN INC (XGN) is 12.